Management of Dermatitis
The management of dermatitis should follow a stepwise approach with moisturizers, topical corticosteroids, topical calcineurin inhibitors, and topical PDE-4 and JAK inhibitors as first-line treatments, with systemic therapies reserved for severe cases unresponsive to topical therapy. 1
First-Line Treatments
Moisturizers and Skin Care
- Apply moisturizers at least twice daily as the foundation of dermatitis management 1, 2
- Use alcohol-free moisturizers, preferably with urea-containing (5-10%) formulations 2
- Use emollients as soap substitutes for cleansing to avoid further irritation 2
- Avoid excessive heat, humidity, and change clothes when damp from sweat 2
- Use gentle, pH-neutral synthetic detergents and non-soap cleansers 2
Topical Anti-inflammatory Treatments
Topical Corticosteroids (TCS)
- Strong recommendation for use in atopic dermatitis 1
- Apply medium-potency TCS (e.g., triamcinolone acetonide 0.1%) as a thin film to affected areas 1-2 times daily for 1-4 weeks 2
- Use lower potency TCS (e.g., hydrocortisone 2.5%) for face, genitals, and intertriginous areas 2
- Limit to short-term use to minimize side effects such as skin atrophy 3
Topical Calcineurin Inhibitors (TCIs)
- Strong recommendation for use 1
- Options include tacrolimus ointment 0.1% or pimecrolimus cream 1% 2, 4
- Particularly useful for sensitive areas (face, neck, intertriginous areas) 4
- FDA-approved as second-line therapy for short-term and non-continuous chronic treatment of mild to moderate atopic dermatitis 4
- Can be used for maintenance therapy to prevent flares 2
Topical PDE-4 Inhibitors
Topical JAK Inhibitors
Second-Line Treatments
Phototherapy
- Conditional recommendation for use in moderate to severe cases unresponsive to topical treatments 1, 5
- Options include narrowband UVB (NB-UVB) for chronic cases and UVA1 for acute cases 5
- Generally considered safe and well-tolerated, but has limitations related to costs, availability, and patient compliance 5
- Should be performed under specialist supervision, especially in children 5
Wet Wrap Therapy
Third-Line Treatments (Severe Cases)
Systemic Therapies
- Reserved for severe, widespread dermatitis unresponsive to topical treatments 1
- Strong recommendations for:
- Conditional recommendations for:
- Immunosuppressants: azathioprine, cyclosporine, methotrexate, mycophenolate 1
- Conditional recommendation against systemic corticosteroids 1
Treatments NOT Recommended
Topical Antimicrobials/Antiseptics
Topical Antihistamines
Special Considerations
Contact Dermatitis
- Identify and avoid triggering substances 7
- For allergic contact dermatitis, mid- or high-potency topical steroids are effective for localized lesions 7
- For extensive involvement (>20% body surface area), systemic steroids may be required 7
Monitoring and Follow-up
- Reassess after 2 weeks of treatment to monitor progress 2
- Watch for signs of skin atrophy, secondary bacterial infection, and treatment failure 2
- Consider dermatology referral if:
- No improvement after 4-9 weeks of appropriate therapy
- Diagnosis is uncertain
- Lesions are widespread or rapidly progressing
- Secondary complications develop 2
Patient Education
- Educate patients about the chronic, relapsing nature of dermatitis 2
- Emphasize the importance of consistent moisturization and trigger avoidance 2
- Explain proper application techniques for medications 2
- Reassure patients that the condition is not infectious or related to poor hygiene 2
By following this structured approach to dermatitis management, clinicians can effectively control symptoms, prevent flares, and improve patients' quality of life while minimizing potential treatment-related adverse effects.